Luiz Carlos Bodanese

ORCID: 0000-0002-3142-7336
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Valve Diseases and Treatments
  • Cardiac Imaging and Diagnostics
  • Public Health in Brazil
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Healthcare Regulation
  • Cardiovascular Function and Risk Factors
  • Venous Thromboembolism Diagnosis and Management
  • Lipoproteins and Cardiovascular Health
  • Atrial Fibrillation Management and Outcomes
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiac and Coronary Surgery Techniques
  • Heart Failure Treatment and Management
  • Diet and metabolism studies
  • Adipokines, Inflammation, and Metabolic Diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Atherosclerosis and Cardiovascular Diseases
  • Blood Pressure and Hypertension Studies
  • Cardiac Arrest and Resuscitation
  • Youth, Drugs, and Violence
  • Healthcare during COVID-19 Pandemic
  • Cardiac pacing and defibrillation studies
  • Vitamin C and Antioxidants Research
  • Microscopic Colitis

Pontifícia Universidade Católica do Rio Grande do Sul
2015-2024

Hospital São Lucas da PUCRS
2009-2023

Vifor Pharma (Switzerland)
2020

Hospital Universitário Clementino Fraga Filho
2018

Universidade de São Paulo
2018

Universidade Federal de Sergipe
2018

Fundación Cardiovascular de Colombia
2017

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2017

Sociedade Brasileira de Cardiologia
2002-2016

Duke Medical Center
2016

10.1590/s0066-782x2007000700002 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2007-04-01

The aim of this study is to compare spironolactone versus clonidine as the fourth drug in patients with resistant hypertension a multicenter, randomized trial. Medical therapy adherence was checked by pill counting. Patients (no office and ambulatory blood pressure [BP] monitoring control, despite treatment 3 drugs, including diuretic, for 12 weeks) were an additional 12-week (12.5–50 mg QD) or (0.1–0.3 BID). primary end point BP control during (<140/90 mm Hg) 24-h (<130/80 monitoring....

10.1161/hypertensionaha.117.10662 article EN Hypertension 2018-02-20
José Carlos Nicolau Gilson Soares Feitosa João Luiz Fernandes Petriz Remo Furtado Dalton Bertolim Précoma and 64 more Walmor Lemke Renato D. Lópes Ari Timerman José Antônio Marin‐Neto Luiz Bezerra Bruno Ferraz de Oliveira Gomes Eduardo Cavalcanti Lapa Santos Leopoldo Soares Piegas Alexandre de Matos Soeiro Alexandre Jorge de Andrade Negri André Franci Brivaldo Markman Bruno Mendonça Baccaro Carlos Eduardo Lucena Montenegro Carlos Eduardo Rochitte Carlos Barbosa Cláudio Marcelo Bittencourt das Virgens Edson Stefanini Euler Roberto Fernandes Manenti Felipe Gallego Lima Francisco das Chagas Monteiro Harry Corrêa Henrique Patrus Mundim Pena Ibraim Pinto João Luiz de Alencar Araripe Falcão Joberto Pinheiro Sena José Maria Peixoto Juliana Ascenção de Souza Leonardo Sara da Silva Lília Nigro Maia Louis Nakayama Ohe Luciano Baracioli Luís Alberto Oliveira Dallan Luís Augusto Palma Dallan Luiz Alberto Mattos Luiz Carlos Bodanese Luiz Eduardo Fonteles Ritt Manoel Fernandes Canesin Marcelo B. Rivas Marcelo Franken Marcos José Gomes Magalhães Múcio Tavares de Oliveira Nivaldo Menezes Filgueiras Óscar Pereira Dutra Otávio Rizzi Coelho Paulo Leães Paulo Roberto Ferreira ROSSI Paulo Rogério Soares Pedro A. Lemos Pedro Sílvio Farsky Rafael Cavalcanti Renato Jorge Alves Renato A. K. Kalil Roberto Esporcatte Roberto Luiz Marino Roberto R. Giraldez Romeu Sérgio Meneghelo Ronaldo de Souza Leão Lima Rui Fernando Ramos Sandra Nívea dos Reis Saraiva Falcão Talia Falcão Dalçóquio Viviana Lemke William Azem Chalela Wilson Mathias

Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instavel e Infarto Agudo do Miocardio sem Supradesnivel Segmento ST – 2021

10.36660/abc.20210180 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2021-07-01
Gorav Batra Tatevik Ghukasyan Lakic Johan Lindbäck Claes Held Harvey D. White and 95 more Ralph Stewart Wolfgang Köenig Christopher P. Cannon Andrzej Budaj Emil Hagström Agneta Siegbahn Lars Wallentin Miguel Bustamante Labarta Luis Cartasegna Sergio Chekherdemian Jose L Cuello Pedro Elías Jorge A Giordano Alfredo Hirschson Miguel Hominal Julio O Ibañez Horacio O Jure Marcos Litvak Stella M. Macı́n Ignacio Jorge MacKinnon Laura Maffei Oscar Montaña Aldo Prado JORGELINA SALA Vanina Gorosito Ramiro Sánchez David Brieger Derek P. Chew D. Cross Ferdinandus J. de Looze A. Farshid Stephen Hall Henry Krum Geoff K Lane Ernesto Oqueli Flores John Stickland Peter W Purnell Gregory Szto Peter L. Thompson Jonathan Waites M. William Christophe Beauloye Jean Boland Filip Charlier Herbert JLP De Raedt Joseph AY Dens Karl Dujardin Alain Friart André Scheen Erwin Schröder Peter Sinnaeve Stefan Verheye Pascal Vranckx JOSE ANTONIO ABRANTES Denílson Campos de Albuquerque Wilma Roberta Ardito Luciano Baracioli Marcelo Chiara Bertolami Luiz Carlos Bodanese Raúl D. Santos Lília Nigro Maia Euler RF Manenti Roberto Luiz Marino Clarisse Kaoru Ogawa Indio do Brasil Maria Sanali de Oliveira Paiva Álvaro Rabelo Alves Salvador Rassi Gilmar Reis Paulo R F Rossi José Francisco K Saraiva Haralambi O Benov Boryana Chompalova Stefan Denchev Assen Goudev Valentina Grigorova Atanas Mihov Valentina M Mincheva С. В. Петрова Angelina Staneva Dimitar Raev S. Tisheva Ronnie Aronson Jacques Bedard RAKESH BHARGAVA David J. Borts Christian Constance Jean R. Cusson Richard F. Davies John Ducas Murdo ER Ferguson Ronald Goldenberg François Grondin Gábor Gyenes Frank Halperin Jan M. Kornder

<h3>Importance</h3> Inflammation promotes cardiovascular disease and anti-inflammatory treatment reduces events in patients with chronic coronary syndrome. Chronic kidney (CKD) is a risk factor for disease. It unclear how inflammation mediated by interleukin 6 (IL-6) CKD linked to <h3>Objective</h3> To investigate associations between IL-6 outcomes syndrome association function. <h3>Design, Setting, Participants</h3> This multicenter cohort study included enrolled at 663 centers 39 countries...

10.1001/jamacardio.2021.3079 article EN JAMA Cardiology 2021-08-25

Chagas' disease is an important cause of cardiomyopathy in Latin America. We aimed to compare clinical characteristics and outcomes patients with heart failure (HF) reduced ejection fraction caused by disease, other etiologies, the era modern HF therapies.This study included 2552 American randomized PARADIGM-HF (Prospective Comparison ARNI With ACEI Determine Impact on Global Mortality Morbidity Heart Failure) ATMOSPHERE (Aliskiren Trial Minimize Outcomes Patients trials. The...

10.1161/circheartfailure.117.004361 article EN Circulation Heart Failure 2017-11-01

AimsPre-clinical and few clinical studies suggest that transplantation of autologous bone marrow mononuclear cells (BMNC) improves heart function in dilated cardiomyopathies. Our objective was to determine if intracoronary injection BMNC the left ventricular ejection fraction (LVEF) patients with non-ischaemic cardiomyopathy (NIDCM).

10.1093/eurheartj/ehv477 article EN European Heart Journal 2015-09-20

Abstract Context: Metabolic syndrome (MS) is described as a cluster of cardiometabolic risk factors. Studies suggest that ischemia-modified albumin (IMA) biomarker cardiovascular diseases. IMA levels could be associated with risks and represent possible indication microvascular dysfunction in MS patients. Objective: To confirm this association, we evaluated the association between MS. Design: We performed case-control study (32 healthy individuals 74 subjects MS) to evaluate MS, IMA, other...

10.1210/jc.2009-1592 article EN The Journal of Clinical Endocrinology & Metabolism 2009-12-17

Objective . The main goal of the present study was to investigate xanthine oxidase (XO) activity in metabolic syndrome subjects submitted a single exercise session. We also investigated parameters oxidative and inflammatory status. Materials/Methods A case-control (9 healthy 8 MS volunteers) performed measure XO, superoxide dismutase (SOD), glutathione peroxidase activities, lipid peroxidation, high-sensitivity C-reactive protein (hsCRP) content, glucose levels, profile. Body mass indices,...

10.1155/2014/587083 article EN Oxidative Medicine and Cellular Longevity 2014-01-01
Aldo P. Maggioni Sally Greene Gregg C. Fonarow Michael Böhm Faı̈ez Zannad and 95 more Scott D. Solomon E. F. Lewis Fabio Baschiera Tien Hua Claudio Gimpelewicz Anastasia Lesogor Mihai Gheorghiade Sergio Rodríguez Ramos Antoni Bayés de Luna Santiago Miriuka Maria Canto Diez Enrico Perna Hugo A Luquez J. G. Pinna Jorge Castagnino Pedro Alvarenga Joaquı́n Ibáñez Edwin Blumberg Claudio Dizeo Rodolfo A. Ahuad Guerrero P. Schygiel R. Milesi Cecilia Sosa Miguel Hominal Leopoldo Márquez C. Poy Eduardo Hasbani Manuel Vico Ana Belén Fernández N Vita Johan Vanhaecke Gilles W. De Keulenaer Harry Striekwold G. Vervoort M. Vrolix P Henry Paul Dendale W. Smolders P Maréchal Hans Vandekerckhove Márcio Galvão Oliveira F. Neuenschwande Gilmar Reis Joana Saraiva Luiz Carlos Bodanese Manoel Fernandes Canesin Oswaldo Tadeu Greco R Bassan R. L. Marino N. Giannetti Gordon W. Moe Bruce Sussex R. Sheppard Thao Huynh Randolph H. Stewart Haisam Haddad L. Echeverria A. Quintero Alcy Torres Mónica Jaramillo Marta López Francisco Javier Otero Mendoza Noel Flórez Carlos Cotes Mercedes García‐Gasalla Jan Bělohlávek J Hradec Martin Peterka P Gregor Z. Monhart Petr Janský Jiří Kettner Paulo Roberto Reichert J. Spinar Tomáš Brabec Martin Hutyra Miroslav Solař Mikko Pietilä Kai Nyman R. Pajari Adam J. Cohen Michel Galinier Philippe Gosse B. Livarek Yannick Neuder Patrick Jourdain Fabienne Picard Richard Isnard U. Hoppe S. Kaeaeb S. Rosocha Roland Prondzinsky S B Felix Hans-Dirk Düengen Hans‐R. Figulla

The objective of the Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) was to determine whether aliskiren, a direct renin inhibitor, would improve post-discharge outcomes in patients with hospitalization for heart failure (HHF) reduced ejection fraction. Pre-specified subgroup analyses suggested potential heterogeneity aliskiren and without baseline diabetes mellitus (DM).ASTRONAUT included 953 DM (aliskiren 489; placebo 464) 662 319; 343) (as reported by study investigators)....

10.1093/eurheartj/eht342 article EN European Heart Journal 2013-09-02

Background: Lifestyle intervention programs can reduce the prevalence of metabolic syndrome (MetS) and, therefore, risk for cardiac disease, one main public health problems nowadays. Objective: The aim this study was to compare effects three types approach lifestyle change in reduction parameters, and identify its impact on quality life (QOL) individuals with MetS. Methods: A randomized controlled trial included 72 MetS aged 30-59 years. Individuals were into groups multidisciplinary...

10.5935/abc.20160186 article EN cc-by-nc Arquivos Brasileiros de Cardiologia 2016-01-01

Despite all progress made in understanding and treating systemic arterial hypertension (SAH), the study of impact psychological disorders SAH is still controversial not well understood. Our aim was to test hypothesis that can be associated with anxiety depressive symptoms verify its effect on quality life.A controlled cross-sectional included 302 patients (152 hypertensive 150 normotensive) outpatients at Hospital São Lucas PUC-RS. Measurements were individual interviews data collection...

10.2190/pm.40.3.f article EN The International Journal of Psychiatry in Medicine 2010-09-01

Purpose To estimate the effect size of a serious game for cardiopulmonary resuscitation (CPR) training in comparison with video-based on-line course terms learning outcomes among medical students before simulation-based CPR using manikin. Methods Participants were 45 first-year randomly assigned to self-training either Apple Keynote presentation (n = 22) or developed 3D environment 23) up 20 min. Each participant was evaluated on written, multiple-choice test (theoretical test) and then...

10.1371/journal.pone.0214722 article EN cc-by PLoS ONE 2019-04-08

The mediastinitis is a serious postoperative complication of cardiac surgery, with an incidence 0.4 to 5% and mortality between 14 47%. Several models were proposed assess risk after surgery. However, most these do not evaluate the morbidity.This study aims develop score model predict for patients undergoing coronary artery bypass grafting.The sample included data from 2,809 adult grafting January 1996 December 2007 at Hospital São Lucas -PUCRS. Logistic regression was used examine...

10.1590/s0102-76382010000200005 article EN cc-by Brazilian Journal of Cardiovascular Surgery 2010-06-01

OBJETIVOS: Analisar o impacto da hemotransfusão sanguínea na incidência de desfechos clínicos no pós-operatório (PO) cirurgias cardíacas. MÉTODOS: Estudo coorte retrospectiva. Foram analisados 4.028 pacientes submetidos à cirurgia revascularização miocárdica (CRM), troca valvar (TV) ou ambas, em hospital terciário universitário brasileiro, entre 1996 e 2009. comparadas as complicações PO os hemotransfundidos (n=916) não-hemotransfundidos (n=3112). Foi realizada análise univariada através do...

10.1590/s0102-76382011000200012 article PT cc-by Brazilian Journal of Cardiovascular Surgery 2011-06-01

A síndrome metabólica é um transtorno complexo representado por conjunto de fatores risco cardiovascular.A adoção estilo vida saudável está fortemente relacionada à melhora da Qualidade Vida e interfere forma positiva no controle dos presentes nessa condição clínica.Objetivo: Avaliar o efeito programa modificação do

10.5935/abc.20140029 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2014-01-01

It now appears that obesity is associated with a low-grade inflammation of white adipose tissue resulting from chronic activation the innate immune system as interleukin-1 beta (IL-1). Previous investigations have described positive association between IL-1 +3953 (C>T) gene polymorphism (rs 1143634) and obesity, suggesting functional effects on fat mass, metabolism body mass. However, it necessary to determine if these results occur in other populations they are influenced by sex age....

10.1016/j.mce.2009.07.029 article EN publisher-specific-oa Molecular and Cellular Endocrinology 2009-08-09

Objective: To determine the risk factors related to development of stroke in patients undergoing cardiac surgery.Methods: A historical cohort study.We included 4626 aged ≥ 18 years who underwent coronary artery bypass surgery, heart valve replacement surgery alone or combined with grafting between January 1996 and December 2011.The relationship predictors was assessed by logistic regression model a significance level 0.05.Results: The incidence 3% overall sample.After regression, following...

10.5935/1678-9741.20140025 article EN cc-by Brazilian Journal of Cardiovascular Surgery 2014-01-01

FUNDAMENTO: Estabelecer escore de risco para cirurgias cardíacas permite avaliar pré-operatório, informar o paciente e definir cuidados durante a intervenção. OBJETIVO: Pesquisar fatores pré-operatórios óbito em cirurgia cardíaca valvar construir um modelo simples (escore) mortalidade hospitalar os pacientes candidatos à no Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande Sul (HSL-PUCRS). MÉTODOS: A amostra estudo inclui 1.086 adultos que realizaram entre Janeiro 1996...

10.1590/s0066-782x2010005000026 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2010-04-01
Coming Soon ...